Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2017
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
P F Ferrucci, P A Ascierto, J Pigozzo, et al.
British Journal of Cancer
|
March 13, 2014
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy
V Chiarion-Sileni, J Pigozzo, P A Ascierto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
P F Ferrucci, P A Ascierto, J Pigozzo, et al.
ESMO Open
|
February 15, 2023
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
A Boutros, A Bottini, G Rossi, et al.
Journal of Translational Medicine
|
May 15, 2024
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort
I Vanni, L Pastorino, V Andreotti, et al.
ESMO Open
|
July 1, 2022
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
W Bruno, B Dalmasso, M Barile, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2017
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
P F Ferrucci, P A Ascierto, J Pigozzo, et al.
British Journal of Cancer
|
March 13, 2014
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy
V Chiarion-Sileni, J Pigozzo, P A Ascierto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
P F Ferrucci, P A Ascierto, J Pigozzo, et al.
ESMO Open
|
February 15, 2023
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
A Boutros, A Bottini, G Rossi, et al.
Journal of Translational Medicine
|
May 15, 2024
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort
I Vanni, L Pastorino, V Andreotti, et al.
ESMO Open
|
July 1, 2022
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
W Bruno, B Dalmasso, M Barile, et al.
Page
of 4